Development Level

Tbio 3 | 10,625
Tclin 2 | 602
Tchem 1 | 1,890

IMPC Term

preweaning lethality, incomple... 1 | 260

Disease

Cancer 5 | 2,346
ovarian cancer 5 | 8,484
psoriasis 5 | 6,685
Breast cancer 4 | 3,094
osteosarcoma 4 | 7,933
Hepatitis B 3 | 103
Hypersensitivity reaction type II disease 3 | 235
head and neck cancer and chronic obstructive pulmonary disease 3 | 237
interstitial cystitis 3 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
invasive ductal carcinoma 3 | 2,950
medulloblastoma, large-cell 3 | 6,234
non-small cell lung cancer 3 | 2,798
tuberculosis 3 | 1,557
Adult T-Cell Lymphoma/Leukemia 2 | 30
Allergic hypersensitivity disease 2 | 123
Arthritis 2 | 248
Asthma 2 | 349
Atopic dermatitis 2 | 944
Dermatitis 2 | 107
Diabetes Mellitus, Insulin-Dependent 2 | 76
Diarrhea 2 | 155
Human immunodeficiency virus infectious disease 2 | 92
Liver disease 2 | 219
Multiple Sclerosis 2 | 498
Rheumatoid Arthritis 2 | 1,160
Type 1 diabetes mellitus 2 | 101
Uveitis 2 | 103
Vasculitis 2 | 64
chronic lymphosyte leukemia 2 | 232
colon cancer 2 | 1,475
cutaneous lupus erythematosus 2 | 1,056
diabetes mellitus 2 | 1,663
ductal carcinoma in situ 2 | 1,745
lung adenocarcinoma 2 | 2,713
lung cancer 2 | 4,466
lung carcinoma 2 | 2,844
oligodendroglioma 2 | 2,849
pancreatic cancer 2 | 2,300
primary pancreatic ductal adenocarcinoma 2 | 1,271
primitive neuroectodermal tumor 2 | 3,031
ulcerative colitis 2 | 2,087
Alcoholic Intoxication, Chronic 1 | 41
Amphetamine-Related Disorders 1 | 74
Amyotrophic Lateral Sclerosis 1 | 431
Astigmatism 1 | 27
Autistic Disorder 1 | 320
Autoimmune thyroiditis 1 | 24
Balkan Nephropathy 1 | 6
Brain disease 1 | 83
Celiac disease 1 | 112
Cerebrovascular disease 1 | 231
Cocaine-Related Disorders 1 | 88
Colitis 1 | 46
Dementia 1 | 129
Exanthem 1 | 39
Gastritis 1 | 44
Gaucher's disease 1 | 24
Graft-vs-Host Disease 1 | 5
Hepatolenticular Degeneration 1 | 24
Huntington's disease 1 | 72
Hypersensitivity 1 | 63
Hypothyroidism 1 | 89
Inflammatory bowel disease 1 | 142
Juvenile rheumatoid arthritis 1 | 104
Kidney disease 1 | 396
Leishmaniasis 1 | 49
Lewy Body Disease 1 | 19
Lichen planus 1 | 17
Liver carcinoma 1 | 217
Lung disease 1 | 132
Lymphoma, T-Cell, Cutaneous 1 | 21
Malaria 1 | 140
Mammary Neoplasms 1 | 410
Manganese Poisoning 1 | 11
Melanoma 1 | 261
Multiple system atrophy 1 | 27
Nerve Degeneration 1 | 73
Neurodegenerative disease 1 | 383
Neuropathy 1 | 210
Pantothenate kinase-associated neurodegeneration 1 | 15
Parkinson Disease 1 | 102
Parkinson's disease 1 | 364
Pick's disease 1 | 14
Primary immunodeficiency disease 1 | 52
Psychoses, Substance-Induced 1 | 17
REM sleep behavior disorder 1 | 16
Substance-Related Disorders 1 | 114
Thyrotoxicosis 1 | 38
Toxic encephalopathy 1 | 131
Transitional cell carcinoma 1 | 18
Tropical spastic paraparesis 1 | 17
X-linked cerebral adrenoleukodystrophy 1 | 115
Yellow fever 1 | 14
atypical teratoid/rhabdoid tumor 1 | 1,095
non-small cell lung carcinoma 1 | 413
sarcoidosis 1 | 358
systemic lupus erythematosus 1 | 156
tuberculosis and treatment for 3 months 1 | 327
uncontrolled asthma 1 | 67

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444

Target Family

Non-IDG 5 | 11,971
Transcription Factor 1 | 1,400

Grant Application

5R01CA164225-04 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Alpha-synuclein SNCA Tchem Non-IDG -3.59982 3997.3 1484
Forkhead box protein P3 FOXP3 Tbio Transcription Factor -3.60057 5680.3 1162
Cytotoxic T-lymphocyte protein 4 CTLA4 Tclin Non-IDG -3.46843 3564.0 656
Programmed cell death 1 ligand 1 CD274 Tclin Non-IDG -3.20982 2228.3 671
V-set domain-containing T-cell activation inhibitor 1 VTCN1 Tbio Non-IDG -2.05577 156.3 396
V-type immunoglobulin domain-containing suppressor of T-cell activation VSIR Tbio Non-IDG -2.82753 683.7 72